New England Journal of Medicine 2023 03 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial Rosenstock J, Frias J, Jastreboff AM, et al
KPV and tributyrin partner to regulate damaging cytokines associated with inflammatory bowel disease, while BPC-157 and PEA calm and fortify the GI lining [8, 30, 31, 32]
In Spodoptera litura , flavonoids containing multiple phenolic hydroxyl groups on the A and B rings exhibited stronger acetylcholinesterase inhibitory activity, with quercetagetin-7-O (6-O-caffeoyl--D-glucopyranoside) showing the highest inhibition potency (Li et al., 2020)
Klein, John M
Baldissera FG, Holst JJ, Knuhtsen S, Hilsted L, Nielsen OV (1988) Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs